Prostalund AB (FRA:7PL0) FFO


FRA:7PL0 Prostalund AB FRA:7PL0
10 GF Score
Price €0.00
GF Value €0.02
! 6 Warning Signs
View Full Analysis

What is Prostalund AB FFO?

FFO (Funds from operations) only applies to REITs.

FRA:7PL0
10GF Score
Prostalund AB FRA:7PL0
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Prostalund AB (FRA:7PL0) Overvalued in 2026?

Based on GuruFocus' analysis, Prostalund AB stock appears to be undervalued. The current stock price of €0.00 is trading 97.5% below its estimated GF Value™ of €0.02.

Key valuation signals for FRA:7PL0:

  • FFO:
  • GF Value™: €0.02 vs. price of €0.00 (97.5% below fair value)
  • GF Score™: 10/100 with 6 warning signs

No single metric tells the full story. See the FRA:7PL0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Prostalund AB Business Description

Address Scheelevagen 19, Lund, SWE, SE-223 63
Prostalund AB develops, markets and sells urological products. The Company has a treatment concept (CoreTherm Concept) for personalized heat treatment for the condition benign prostatic hyperplasia, also known as BPH or BPE, which mainly affects men over the age of 50. It has developed a new platform, CoreTherm Eagle which includes an inbuilt computer, real-time temperature reading, patient data storage and inbuilt recommendations for treating physicians.
10GF Score

Get the complete analysis for FRA:7PL0

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.00
Price
€0.02
GF Value